CA2740974A1 - Formes galeniques destinees a une elevation rapide et prolongee du ph gastrique - Google Patents

Formes galeniques destinees a une elevation rapide et prolongee du ph gastrique Download PDF

Info

Publication number
CA2740974A1
CA2740974A1 CA2740974A CA2740974A CA2740974A1 CA 2740974 A1 CA2740974 A1 CA 2740974A1 CA 2740974 A CA2740974 A CA 2740974A CA 2740974 A CA2740974 A CA 2740974A CA 2740974 A1 CA2740974 A1 CA 2740974A1
Authority
CA
Canada
Prior art keywords
dosage form
present
pharmaceutical composition
ppi
blocker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2740974A
Other languages
English (en)
Inventor
John R. Plachetka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pozen Inc
Original Assignee
Pozen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pozen Inc filed Critical Pozen Inc
Publication of CA2740974A1 publication Critical patent/CA2740974A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2740974A 2008-05-30 2009-05-29 Formes galeniques destinees a une elevation rapide et prolongee du ph gastrique Abandoned CA2740974A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12902908P 2008-05-30 2008-05-30
US61/129,029 2008-05-30
PCT/US2009/003281 WO2009145905A1 (fr) 2008-05-30 2009-05-29 Formes galéniques destinées à une élévation rapide et prolongée du ph gastrique

Publications (1)

Publication Number Publication Date
CA2740974A1 true CA2740974A1 (fr) 2009-12-03

Family

ID=41377439

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2740974A Abandoned CA2740974A1 (fr) 2008-05-30 2009-05-29 Formes galeniques destinees a une elevation rapide et prolongee du ph gastrique

Country Status (3)

Country Link
EP (1) EP2364145A4 (fr)
CA (1) CA2740974A1 (fr)
WO (1) WO2009145905A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
CN1559612A (zh) * 2004-02-18 2005-01-05 孔庆忠 一种治疗消化系统溃疡药物组合物
US20060165797A1 (en) * 2005-01-12 2006-07-27 Pozen Inc. Dosage form for treating gastrointestinal disorders
EP2486910A3 (fr) * 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Appareil comprenant plusieurs chambres et une tête de distribution

Also Published As

Publication number Publication date
WO2009145905A1 (fr) 2009-12-03
EP2364145A4 (fr) 2013-11-13
EP2364145A1 (fr) 2011-09-14

Similar Documents

Publication Publication Date Title
US20060165797A1 (en) Dosage form for treating gastrointestinal disorders
US9636306B2 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
EP1411900B1 (fr) Compositions pharmaceutiques destinees a la liberation coordonnee d'ains
US6605303B1 (en) Oral pharmaceutical extended release dosage form
US20150125524A1 (en) Pharmaceutical compositions for the coordinated delivery of nsaids
US20100178334A1 (en) Oral Pharmaceutical Dosage Form Comprising as Active Ingredients a Proton Pump Inhibitor together with Acetyl Salicyclic Acid
JP2012153712A (ja) 胸やけの処置法
CA2740974A1 (fr) Formes galeniques destinees a une elevation rapide et prolongee du ph gastrique
WO2017084680A1 (fr) Composition pharmaceutique contenant un médicament anti-inflammatoire non stéroïdien et un inhibiteur de pompe à protons
WO2011080502A2 (fr) Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
WO2013122554A1 (fr) Formulations de pastilles comprenant de l'ésoméprazole
JP2007504261A (ja) プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
EP2015731B1 (fr) Compositions pharmaceutiques contenant un médicament anti-inflammatoire non stéroïdien, acétaminophène et un inhibiteur de la pompe à protons
EP1841409A2 (fr) Forme dosifiee contre les troubles gastro-intestinaux
WO2009137648A1 (fr) Pastilles multicouches inhibant la pompe à protons
WO2012162777A9 (fr) Composition pharmaceutique orale comprenant un inhibiteur de la pompe à protons et un agent prokinétique, à utiliser en cas de troubles liés à l'excès d'acide gastrique

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150529